ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 136 filers reported holding ENANTA PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 0.38 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $1,000 | 0.0% | 12 | 0.0% | 0.00% | – |
| Q3 2019 | $1,000 | -66.7% | 12 | -69.2% | 0.00% | – |
| Q2 2019 | $3,000 | 0.0% | 39 | +44.4% | 0.00% | – |
| Q1 2019 | $3,000 | -40.0% | 27 | -63.5% | 0.00% | – |
| Q4 2018 | $5,000 | -72.2% | 74 | -91.3% | 0.00% | – |
| Q2 2016 | $18,000 | -30.8% | 849 | -4.8% | 0.00% | – |
| Q1 2016 | $26,000 | +8.3% | 892 | +22.2% | 0.00% | – |
| Q4 2015 | $24,000 | -27.3% | 730 | -21.5% | 0.00% | -100.0% |
| Q3 2015 | $33,000 | -19.5% | 930 | +1.9% | 0.00% | 0.0% |
| Q2 2015 | $41,000 | +46.4% | 913 | 0.0% | 0.00% | 0.0% |
| Q1 2015 | $28,000 | -94.5% | 913 | -91.0% | 0.00% | -90.9% |
| Q4 2014 | $513,000 | +5030.0% | 10,098 | +3710.6% | 0.01% | – |
| Q3 2014 | $10,000 | – | 265 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 906,930 | $19,998,000 | 7.20% |
| McClain Value Management LLC | 186,850 | $4,120,000 | 3.51% |
| GREAT POINT PARTNERS LLC | 538,024 | $11,863,000 | 3.40% |
| SENZAR ASSET MANAGEMENT, LLC | 482,000 | $10,628,100,000 | 2.32% |
| ARMISTICE CAPITAL, LLC | 240,000 | $5,292,000 | 2.02% |
| EcoR1 Capital, LLC | 136,882 | $3,018,000 | 1.19% |
| Matarin Capital Management, LLC | 236,690 | $5,219,015,000 | 0.71% |
| Spark Investment Management LLC | 293,100 | $6,462,000 | 0.60% |
| HAYS ADVISORY LLC | 172,557 | $3,805,000 | 0.59% |
| Virtus ETF Advisers LLC | 23,292 | $514,000 | 0.38% |